Correlation Between Pasithea Therapeutics and Kymera Therapeutics
Can any of the company-specific risk be diversified away by investing in both Pasithea Therapeutics and Kymera Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pasithea Therapeutics and Kymera Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pasithea Therapeutics Corp and Kymera Therapeutics, you can compare the effects of market volatilities on Pasithea Therapeutics and Kymera Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pasithea Therapeutics with a short position of Kymera Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pasithea Therapeutics and Kymera Therapeutics.
Diversification Opportunities for Pasithea Therapeutics and Kymera Therapeutics
-0.38 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Pasithea and Kymera is -0.38. Overlapping area represents the amount of risk that can be diversified away by holding Pasithea Therapeutics Corp and Kymera Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kymera Therapeutics and Pasithea Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pasithea Therapeutics Corp are associated (or correlated) with Kymera Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kymera Therapeutics has no effect on the direction of Pasithea Therapeutics i.e., Pasithea Therapeutics and Kymera Therapeutics go up and down completely randomly.
Pair Corralation between Pasithea Therapeutics and Kymera Therapeutics
Assuming the 90 days horizon Pasithea Therapeutics Corp is expected to generate 7.36 times more return on investment than Kymera Therapeutics. However, Pasithea Therapeutics is 7.36 times more volatile than Kymera Therapeutics. It trades about 0.16 of its potential returns per unit of risk. Kymera Therapeutics is currently generating about 0.06 per unit of risk. If you would invest 2.19 in Pasithea Therapeutics Corp on October 20, 2024 and sell it today you would earn a total of 0.32 from holding Pasithea Therapeutics Corp or generate 14.61% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 50.0% |
Values | Daily Returns |
Pasithea Therapeutics Corp vs. Kymera Therapeutics
Performance |
Timeline |
Pasithea Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
OK
Kymera Therapeutics |
Pasithea Therapeutics and Kymera Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Pasithea Therapeutics and Kymera Therapeutics
The main advantage of trading using opposite Pasithea Therapeutics and Kymera Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pasithea Therapeutics position performs unexpectedly, Kymera Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kymera Therapeutics will offset losses from the drop in Kymera Therapeutics' long position.The idea behind Pasithea Therapeutics Corp and Kymera Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Kymera Therapeutics vs. Foghorn Therapeutics | Kymera Therapeutics vs. Shattuck Labs | Kymera Therapeutics vs. Monte Rosa Therapeutics | Kymera Therapeutics vs. Nurix Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Complementary Tools
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |